Coeptis Therapeutics Inc. Quarterly Depreciation, Depletion and Amortization in USD from Q1 2020 to Q1 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Summary
Coeptis Therapeutics Inc. quarterly/annual Depreciation, Depletion and Amortization history and growth rate from Q1 2020 to Q1 2022.
  • Coeptis Therapeutics Inc. Depreciation, Depletion and Amortization for the quarter ending March 31, 2022 was $250K.
  • Coeptis Therapeutics Inc. annual Depreciation, Depletion and Amortization for 2021 was $447K, a 38.3% increase from 2020.
Depreciation, Depletion and Amortization, Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2022 $250K +$250K Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-12
Q1 2021 $481* $0 Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q1 2020 $481* Jan 1, 2020 Mar 31, 2020 10-Q/A 2021-05-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.